These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 11504788)

  • 1. Biphasic alterations of cAMP levels and inhibition of norepinephrine release in iris-ciliary body by bremazocine.
    Russell KR; Potter DE
    J Pharmacol Exp Ther; 2001 Sep; 298(3):941-6. PubMed ID: 11504788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kappa opioid agonist-induced changes in IOP: correlation with 3H-NE release and cAMP accumulation.
    Moore TT; Potter DE
    Exp Eye Res; 2001 Aug; 73(2):167-78. PubMed ID: 11446767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of bremazocine, a kappa-opioid receptor agonist, on inositol phosphate formation in isolated iris-ciliary bodies.
    Dortch-Carnes J; Potter DE
    Pharmacology; 2002 Oct; 66(2):100-6. PubMed ID: 12207117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of cAMP accumulation by kappa-receptor activation in isolated iris-ciliary bodies: role of phosphodiesterase and protein kinase C.
    Dortch-Carnes J; Potter DE
    J Pharmacol Exp Ther; 2002 May; 301(2):599-604. PubMed ID: 11961062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of ocular hydrodynamics and iris function by bremazocine, a kappa opioid receptor agonist.
    Russell KR; Wang DR; Potter DE
    Exp Eye Res; 2000 May; 70(5):675-82. PubMed ID: 10870526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delta-opioid agonist-stimulated inositol phosphate formation in isolated, rabbit iris-ciliary bodies: role of G(i/o) proteins and Gbetagamma-subunits.
    Dortch-Carnes J; Potter DE
    Exp Eye Res; 2003 Dec; 77(6):647-52. PubMed ID: 14609552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha-2 adrenoceptor mediated changes in aqueous dynamics: effect of pertussis toxin.
    Ogidigben M; Chu TC; Potter DE
    Exp Eye Res; 1994 Jun; 58(6):729-36. PubMed ID: 7925712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of U50488 and bremazocine on [Ca2+]i and cAMP in naive and tolerant rat ventricular myocytes: evidence of kappa opioid receptor multiplicity in the heart.
    Zhang WM; Wu S; Yu XC; Wang HX; Bian JS; Wong TM
    J Mol Cell Cardiol; 1999 Feb; 31(2):355-62. PubMed ID: 10093048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ocular action of an opioid peptide, DPDPE.
    Wang D; Potter DE
    J Ocul Pharmacol Ther; 1996; 12(2):131-9. PubMed ID: 8773929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rilmenidine-induced ocular hypotension: role of imidazoline1 and alpha 2 receptors.
    Chu TC; Wong W; Gluchowski C; Hughes BW; Potter DE
    Curr Eye Res; 1996 Sep; 15(9):943-50. PubMed ID: 8921215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Naphazoline-induced neuroendocrine changes: increases in ANP and cGMP levels, but suppression of NE, 3H-NE, and cAMP levels in rabbit eyes.
    Ogidigben MJ; Chu TC; Potter DE
    Pharmacology; 2002 Jul; 65(3):155-61. PubMed ID: 12037379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevation of atrial natriuretic peptide levels in aqueous humor of the rabbit by kappa opioid receptor agonists.
    Russell KR; Moore TT; Potter DE
    Neuropeptides; 2001; 35(5-6):232-7. PubMed ID: 12030807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 8OH-DPAT-Induced ocular hypotension: sites and mechanisms of action.
    Chu TC; Ogidigben MJ; Potter DE
    Exp Eye Res; 1999 Aug; 69(2):227-38. PubMed ID: 10433858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prejunctional alpha 2-adrenoceptors and adenylyl cyclase regulation in the rabbit iris-ciliary body.
    Jumblatt JE
    J Ocul Pharmacol; 1994; 10(4):617-21. PubMed ID: 7714405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ocular hypotensive action of a dopaminergic (DA2) agonist, 2,10,11-trihydroxy-N-n-propylnoraporphine.
    Ogidigben M; Chu TC; Potter DE
    J Pharmacol Exp Ther; 1993 Nov; 267(2):822-7. PubMed ID: 7902435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lisuride acts at multiple sites to induce ocular hypotension and mydriasis.
    Potter DE; Ogidigben MJ; Chu TC
    Pharmacology; 1998 Nov; 57(5):249-60. PubMed ID: 9742290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Supersensitization of the adenylyl cyclase system in Chinese hamster ovary cells co-expressing cloned opioid receptors and Gz, a PTX-insensitive G protein.
    Ozawa T; Nakagawa T; Minami M; Satoh M
    Neurosci Lett; 1999 May; 267(2):117-20. PubMed ID: 10400226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of adenylate cyclase in bovine ciliary process and rabbit iris ciliary body to alpha 2-adrenergic agonists.
    Jin Y; Elko EE; Tran T; Yorio T
    J Ocul Pharmacol; 1989; 5(3):189-97. PubMed ID: 2576279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ocular actions of moxonidine: a possible role for imidazoline receptors.
    Ogidigben M; Chu TC; Potter DE
    J Pharmacol Exp Ther; 1994 Jun; 269(3):897-904. PubMed ID: 7912282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The kappa opioid receptor expressed on the mouse R1.1 thymoma cell line is coupled to adenylyl cyclase through a pertussis toxin-sensitive guanine nucleotide-binding regulatory protein.
    Lawrence DM; Bidlack JM
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1678-83. PubMed ID: 8103800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.